Regulations.gov document
Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products…
Notice · FDA-2024-D-1243 · posted Apr 30, 2024
Key facts
| Document ID | FDA-2024-D-1243-0001 |
|---|---|
| Title | Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2024-D-1243 |
| Posted | Apr 30, 2024 |
| Federal Register citation | 89 FR 34251 |
| FR document number | 2024-09287 |
| Effective date | Apr 30, 2024 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: